Vision TeKardio 1.0

Herr Dr. jur. Christoph J. Partsch (LLM Duke Univ., USA) ist seit 1995 tätig als Rechtsanwalt und Unternehmer. Nach seinen Studien der Rechtswissenschaften, Medizin und Kunstgeschichte in Bonn, Freiburg, Kiel und Genf hat er sein 2. juristisches Staatsexamen 1994 in Berlin abgelegt. An der Duke University, Durham, USA, hat er zudem einen Master of the Laws erlangt. Bei Prof. Dr. Schmidt-Jortzig in Kiel hat er einen Dr. jur. zum Informationsfreiheitsrecht erworben. Frau Dr. Annett Kröttinger, ärztliche Leiterin der Deutschen Stiftung für chronisch Kranke, koordiniert und supervidiert die medizinischen Aspekte aller durch die Stiftung organisierten telemedizinischen Programme. Aufgrund ihrer Tätigkeit in der ambulanten Patienten- versorgung verfügt sie über umfassende Kenntnisse des deutschen Gesundheitswesens. Durch ihre Ausbildung zumMaster of Public Health an der Harvard Universität sowie ihrer Beratungstä- tigkeit für McKinsey & Co. hat sie sich umfassende Managementfähigkeiten angeeignet. D.5 Literatur Aldini, G. (1804). Theoretisch-praktischer Versuch über den Galvanismus. Mit einer Reihe von Experimenten, welche in Gegenwart der Commissarien des National-Instituts und in verschiedenen anatomischen Sälen in London ange- stellt wurden. Mit Zusätzen und Anmerkungen bearbeitet von Franz Heinrich Martens. Leipzig: Hinrichs. Al-Khatib, S.M., Piccini, J.P., Knight, D., Stewart, M., Clapp-Channing, N., Sanders, G.D. (2010). Remote monitoring of implantable cardioverter defibrillators versus quarterly device interrogations in clinic: results from a randomized pilot clinical trial. J Cardiovasc Electrophysiol 21, 545 – 550. Alter, P. et al. (2005), Complications of Implantable Cardioverter Defibrillator - Therapy in 440 Consecutive Patients. PACE 28, 926 – 932. Ando, K., Koyama, J., Abe, Y., Sato, T., Shoda, M., Soga, Y., Nobuyoshi, M., Honda, T., Nakao, K., Terata, K., Kadowaki, K., Maeda, A., Ogawa, S., Manaka, T., Hagiwara, N., Doi, K. (2011). Feasibility evaluation of a remote monitoring system for im- plantable cardiac devices in Japan. Int Heart J. 52 (1), 39 – 43. Arora, N.K.,Weaver, K.E.,Clayman, M.L.,Oakley-Girvan, I., Potosky, A.L. (2009). Phy- sicians’ decision-making style and psychosocial outcomes among cancer survi- vors. Patient Education and Counseling 77 3, 404 – 412. Bartlett, E.E. (2003). The Contributions of Consumer Health Education to Prima- ry Care Practice: A Review. Medical Care 18 8: 862 – 871. Beolchi, L. (2003). Telemedicine Glossary, 5 th edition, Brussels. Berger Kurzen, B. (2004). E-Health und Datenschutz, Zürich. Bichat, M.F.X. (1800). Recherches physiologiques sur la vie et la mort. Paris : Brosson, Gabon et Cie. Biermann, J. et al. (2009). Heart failure: the commonest reason for hospital ad- mission in Germany: medical and economic perspectives. Dtsch Arztebl Int.; 106 (16), 269 – 275. Borleffs, C. et al. (2009). Clinical importance of new-onset atrial fibrillation after cardiac resynchronization therapy. Heart Rhythm 6: 305 – 310. Bourge, R. C., Abraham, W. T., Adamson, P. B., Aaron, M. F., Aranda, J. M., Magalski, A. et al. (2008). Randomized controlled trial of an implantable continuous he- modynamic monitor in patients with advanced heart failure: The COMPASS-HF study. Journal of the American College of Cardiology, 51 (11), 1073 – 1079. Böttcher, W., Merkle, F., Weitkemper, H.-H. (2003). Historische Entwicklung der künstlichen Stimulation des Herzens. Herz- Thorax- Gefäßchir 17, 24 – 34. Bratton, R.L., Cody, C. (2000). Telemedicine applications in primary care: a geriatric patient pilot project. Mayo Clin Proc. 75 (4), 365 – 8. Bristow, M.R. et al. (2004). Cardiac-Resynchronization Therapy with or without an Implantable Defibrillator in Advanced Chronic Heart Failure (COMPANION). N Engl J Med 350: 2140 – 2150. Broens, T. H. F. Huis, R. M. H. A., Vollenbroek-Hutten, M., M., R., Hermens, H. J., Van Halteren, A. T. & Nieuwenhuis, L. J. M. (2007). Determinants of successful telemedicine implementations: A literature study. Journal of Telemedicine and Telecare, 13 (6), 303 – 309. Brugada 2005 Brugada, P. (2006). What evidence do we have to replace inhospital implantable cardioverter defibrillator follow-up? Clinical Research in Cardiology: Official Journal of the German Cardiac Society, 95 (Suppl. 3), iii3 – iii9. Burg, G. (2001). ExpertenforumMVZ, in: Facharzt.de (online unter: http://fach- arzt.de/ , Stand: 23.11.2007) Burri, H., Senouf, D. (2009). Remote monitoring and follow-up of pacemakers and implantable cardioverter defibrillators. Europace 11 (6), 701 – 709. Burri, H., Quesada, A., Ricci, R.P., Boriani, G., Davinelli, M., Favale, S., Da Costa, A., Kautzner, J., Moser, R., Navarro, X., Santini, M. (2010). The MOnitoring Resynchro- nization dEvices and CARdiac patiEnts (MORE-CARE) study: rationale and design. Am Heart J. 160(1), 42 – 48. Burri, H., Heidbüchel, H., Jung, W., Brugada, P. (2011). Remote monitoring: a cost or an investment? Europace 13 Suppl 2: ii44 – 8. Calcagnini, G., Censi, F., Floris, M., Pignalberi, C., Ricci, R., Biancalana, G., et al. (2006). Evaluation of electromagnetic interference of GSMmobile phones with pacemakers featuring remote monitoring functions. Pacing and Clinical Elec- trophysiology 29(4), 380 – 385. Carlson, M. D., Wilkoff, B. L., Maisel, W. H., Carlson, M. D., Ellenbogen, K. A., Sa- xon, L. A. et al. (2006). Recommendations from the Heart Rhythm Society Task Force on Device Performance Policies and Guidelines Endorsed by the American College of Cardiology Foundation (ACCF) and the American Heart Association (AHA) and the International Coalition of Pacing and Electrophysiology Organi- zations (COPE). Heart Rhythm 3 (10), 1250 – 1273. Castellanos, A., Lemberg, L., Jude, J.R., Mobin-Uddin, K., Berkovits, B.V. (1968). Im- plantable Demand Pacemaker. Brit. Heart J. 30, 29. Charles, R. et al. 2007, UK Pacemakers and implantable Defibrillator National Survey 2006, www.devicesurvey.com Chen, J., Wilkoff, B. L., Choucair, W., Cohen, T. J., Crossley, G.H., Johnson, W. B. et al. (2008). Design of the Pacemaker REmote Follow-up Evaluation and Review (PREFER) trial toassess the clinical value of the remote pacemaker interrogation in the management of pacemaker patients. Trials 9, 18. Clark, R. A., Inglis, S. C., McAlister, F. A., Cleland, J. G., Stewart, S. (2007). Telemoni- toring or structured telephone support programmes for patients with chronic heart failure: Systematic review and meta-analysis. BMJ (Clinical Research Ed), 334 (7600), 942. Cleland, J.G., Louis, A.A., Rigby, A.S., Janssens, U. et al. (2005). Noninvasive home telemonitoring for patients with heart failure at high risk of recurrent admis- sion and death: the Trans-European Network-Home-Care Management System (TEN-HMS) study. J Am Coll Cardiol 45(10), 1654 – 64. Clementy, J. et al (2003). Home Monitoring for pacemaker implanted patients. First experience, first results. Mediterr J Pacing Electrophysiol 5, 111 – 114. Crossley, G., Boyle, A., Vitense, H., Sherfesee, L., Mead, R.H. et al. (2008). Trial de- sign in the clinical evaluation of remote notification to reduce time to clinical decision: the Clinical evaluation Of remote NotificatioN to rEduCe Time to clini- cal decision (CONNECT) study. A Heart J 156:840 – 846. Crossley, G.H., Boyle, A., Vitense, H., Chang, Y., Mead, R.H. (2011). The CONNECT (Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision) trial: the value of wireless remote monitoring with automatic clinician alerts. J Am Coll Cardiol. 57(10): 1181 – 9. Delarche, N., Bizeau, O., Couderc, P., Chapelet, A., Amara, W., Lazarus, A. (2011). Home Monitoring assessment of cardiac resynchronization therapy: The SUPOR- T study. Europace Journal 13(3), P1159. De Ruvo, E., Pisano’, E., Quaglione, R., Sciarra, L., De Luca, L., Lioy, E., Zuccaro, L. , Rebecchi, M., Gargaro, A., Calo’, L. (2011). Long-term risk reduction of misdetec- tion or delayed detection of adverse events with a daily remote control system in patients with cardiac resynchronization therapy defibrillators. European Heart Journal 32 (suppl 1), 147. De Ruvo, E., Sciarra, L., Rebecchi, M., Stirpe, F., De Luca, L., Zuccaro, L.M., Sangio- vanni, L., Fagagnini, A., Sforza, M., Miniati, M., Gargaro, A., Calò, L. (2011). Effect of periodicity of transmissions in adverse event detection rate in remotely moni- tored implantable cardioverter defibrillators. A comparison between four remo- te systems. Journal of Cardiovascular Electrophysiology 22(Suppl 1), 76. Dubner, S., Auricchio, A., Steinberg, J.S., Vardas, P., Stone, P., Brugada, J., Piotro- wicz, R., Hayes, D.L., Kirchhof, P., Breithardt, G., Zareba, W., Schuger, C., Aktas, M.K., Chudzik, M., Mittal, S., Varma, N. (2012). ISHNE/EHRA expert consensus on remote monitoring of cardiovascular implantable electronic devices (CIEDs) Ann Noninvasive Electrocardiol. 17 (1), 36 – 56. Eckstein, J. et al. (2008). Necessity for surgical revision of defibrillator leads im- planted long-term: causes and management. Circulation May 27; 117(21): 2727 – 2733. 98 99